Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „older“
Suchtreffer
Begriffe & Kennungen
Azacitidine Mylan · 4.8 · Adult population aged 65 years or older with AML with > 30% marrow blasts The most common serious adverse reac
Eintrag öffnenAzacitidine betapharm · 4.8 · 6 Adult population aged 65 years or older with AML with > 30 % marrow blasts The most common serious adverse r
Eintrag öffnenBenzenderivate
Eintrag öffnenBimervax · 4.8 · 5 Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Individuals 18 years of age and older The most common adverse reactions reported after a booster dose with BIM
Eintrag öffnenBimervax · 4.8 · Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnenBimervax · 4.8 · Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnenBimervax · 4.8 · Table 1: Adverse reactions from BIMERVAX clinical trials in individuals 12 years of age and older
Eintrag öffnenBrintellix · 4.8 · Class effect Epidemiological studies, mainly conducted in patients 50 years of age and older, show an increase
Eintrag öffnenBrintellix · 4.8 · Class effect Epidemiological studies, mainly conducted in patients 50 years of age and older, show an increase
Eintrag öffnenBrukinsa · 4.8 · Of the 1 550 patients treated with BRUKINSA monotherapy, 61.3% were 65 years of age or older. The incidence of
Eintrag öffnenBrukinsa · 4.8 · Of the 1 550 patients treated with BRUKINSA monotherapy, 61.3% were 65 years of age or older. The incidence of
Eintrag öffnenBurkholderia
Eintrag öffnenBurkholderia cenocepacia
Eintrag öffnenBurkholderia cepacia
Eintrag öffnenBurkholderia gladioli
Eintrag öffnenBurkholderia mallei
Eintrag öffnen